Unique ID issued by UMIN | UMIN000056109 |
---|---|
Receipt number | R000064112 |
Scientific Title | An exploratory clinical trial to elucidate the mechanism of glucose metabolism regulation using graduated hyperglycemic clamp method in non-diabetic subjects |
Date of disclosure of the study information | 2024/11/08 |
Last modified on | 2024/11/08 22:51:32 |
An exploratory clinical trial to elucidate the mechanism of glucose metabolism regulation using graduated hyperglycemic clamp method in non-diabetic subjects
An exploratory clinical trial using the graduated hyperglycemic clamp method
An exploratory clinical trial to elucidate the mechanism of glucose metabolism regulation using graduated hyperglycemic clamp method in non-diabetic subjects
An exploratory clinical trial to elucidate the mechanism of glucose metabolism regulation using graduated hyperglycemic clamp method
Japan |
Non-diabetes
Endocrinology and Metabolism | Adult |
Others
NO
To study a new mathematical model incorporating the flow of glucose effectiveness (insulin-independent glucose uptake) and to examine the validity of the new model
Others
Relevance of insulin action on elevated blood glucose
Exploratory
Examination of fitting of a novel mathematical model incorporating glucose effectiveness
Relevance of insulin action on elevated blood glucose
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Medicine |
Performing a glucose clamp test on non-diabetic individuals
20 | years-old | <= |
Not applicable |
Male and Female
(1) not diagnosed with diabetes
(2) be at least 20 years of age at the time of informed consent
(3) have been fully informed of the purpose of participation in this study, and have given written consent of their own free will based on a thorough understanding of the purpose of the study
(1) The individuals who are taking drugs that affect glucose metabolism (steroids, immunosuppressants, beta-blockers)
(2) pregnant or possibly pregnant
(3) The individuals who are breast-feeding
(4) The individuals have a known history of hypersensitivity to the test drug or the ingredients in the test
(5) The individuals who have received a cardiac function classification of 3 or 4 by NYHA within the last 1 year
(6) The individuals who have been diagnosed with severe renal dysfunction (eGFR 30 mL/min/1.73 m2 or less) within the last 1 year
(7) Persons with blood clotting abnormalities
(8) The individuals who have been diagnosed with thyroid function abnormalities or electrolyte within the last 1 year
(9) In addition, when the principal investigator deems the patient to be inappropriate as a subject
7
1st name | Kazuhiko |
Middle name | |
Last name | Sakaguchi |
Kobe university
Department of Diabetes and Endocrinology
650-0017
7-5-2, Kusunoki-Cho, Chuo-ku, Kobe
078-382-5861
kzhkskgc@med.kobe-u.ac.jp
1st name | Kazuhiko |
Middle name | |
Last name | Sakaguchi |
Kobe university
Department of Diabetes and Endocrinology
650-0017
7-5-2, Kusunoki-Cho, Chuo-ku, Kobe
078-382-5861
kzhkskgc@med.kobe-u.ac.jp
Kobe university
Others
Other
Intervention research ethics revies committee
7-5-2, Kusunoki-Cho, Chuo-ku, Kobe
0783826669
kainyu@med.kobe-u.ac.jp
NO
2024 | Year | 11 | Month | 08 | Day |
Unpublished
Preinitiation
2024 | Year | 11 | Month | 08 | Day |
2025 | Year | 01 | Month | 01 | Day |
2027 | Year | 03 | Month | 31 | Day |
2024 | Year | 11 | Month | 08 | Day |
2024 | Year | 11 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064112